Contipro was recently inspected by US Food und Drugs Administration (US FDA).

The inspection confirmed that Contipro's facility is operating in accordance with the US Food, Drung and Cosmetic Act with regulations set forth in Title 21 of the US Code for Federal regulations that are applicable for phamaceutical grade of Sodium Hyalurate (HA) produced by the company, and all relevant laws that the USFDA enforces.

Congratulations to Contipro for the successful result!